Documentos de Khunti K. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Área de conocimiento: "Medicina interna"

Subtipo de publicación

Publisher

New England Journal of Medicine(2)

European Heart Journal(1)

Área temáticas

Enfermedades(4)

Farmacología y terapéutica(2)

Fisiología humana(2)

Medicina y salud(2)

Salud y seguridad personal(2)

Área de conocimiento

Enfermedad cardiovascular(4)

Año de Publicación

Origen

Palabras Claves

Cardiovascular disease(2)

Primary Prevention(2)

Blood pressure(1)

Blood-pressure and cholesterol lowering in persons without cardiovascular disease

Abstract: BACKGROUND Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol increase t

Palabras claves:

Accini J.L., Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., McKelvie R., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Pogue J., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.

Blood-pressure lowering in intermediate-risk persons without cardiovascular disease

Abstract: BACKGROUND Antihypertensive therapy reduces the risk of cardiovascular events among high-risk person

Palabras claves:

Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., McKelvie R., Molina D.I., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Pogue J., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Wilkinson J., Xavier D., Yusoff K., Yusuf S., Zhu J.

Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Tria

Abstract: Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation-3) found that antihyp

Palabras claves:

Blood pressure, candesartan, Cardiovascular disease, Lipoprotein, Primary Prevention, statin

Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Gao P., Hart R.G., Held C., Khunti K., Leiter L.A., Lewis B.S., Lonn E.M., Pais P., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Reid C.M., Sliwa K., Toff W.D., Yusoff K., Yusuf S., Zhu J.

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

Abstract: Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) e

Palabras claves:

Cardiovascular disease, Primary Prevention, statins

Avezum A.J., Bosch J.J., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Joseph P.G., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.